BUD FLANAGAN LEUKAEMIA FUND LIMITED
Supporting various institutions in carrying out research into the causes, diagnosis and treatment of Leukaemia and the relief of those suffering from the disease.
Financial health, per its FY2024 accounts
The accounts state that the charity reported a net deficit of £675 for the year, resulting in total unrestricted funds increasing to £773,385. The trustees maintain that the charity has adequate resources to continue in operational existence for the foreseeable future, with free reserves of £143,385 held at year-end. The charity is dependent on voluntary support and income from donations and rental properties to pursue its objectives.
What the accounts disclose
“It is a policy of the charity that sufficient reserves are maintained to meet its current commitments and to pursue its activities for the foreseeable future.” — page 4
“In 2019, the charity purchased a property from Ms Rudland-Wood, company secretary, for the amount of £160,000. It was purchased at an amount below market value on the basis that Ms Rudland-Wood would pay for the cost of modernising the property.” — page 16
Property (HM Land Registry)
Trustees
- Geraldine Smith
- Kim Anthonia Smith
- MARTIN JOHN KING
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £31k | £32k |
| 31/12/2023 | £25k | £28k |
| 31/12/2022 | £25k | £16k |
| 31/12/2021 | £29k | £25k |
| 31/12/2020 | £9k | £20k |
Common questions
Is BUD FLANAGAN LEUKAEMIA FUND LIMITED financially healthy?
Per its FY2024 accounts: The accounts state that the charity reported a net deficit of £675 for the year, resulting in total unrestricted funds increasing to £773,385. The trustees maintain that the charity has adequate resources to continue in operational existence for the foreseeable future, with free reserves of £143,385 held at year-end. The charity is dependent on voluntary support and income from donations and rental properties to pursue its objectives. Its FY2024 accounts were independently examined.